Erin VanDyke on Why They Do In-person Site Visits for NBCA Centers of Excellence Designation!
Erin VanDyke, Vice President of NBCA Centers of Excellence, shared on LinkedIn:
”“Why do you do in-person site visits for COE designation?”
It’s a question I get asked often — and honestly, it’s one of my favorite parts of the process to talk about.
At National Blood Clot Alliance, we believe that achieving a Center of Excellence designation should reflect more than the strength of one service line.
It should represent a hospital-wide commitment to improving every aspect of VTE prevention, diagnosis, treatment, follow-up, and community awareness.
That’s why the site visit matters so much.
Being there in person allows us to see and feel the culture — how the team communicates, how barriers are approached, and how deeply VTE awareness is woven into the organization.
It gives us a chance to meet the people who make the work happen — from the physicians and APPs to the nurses, pharmacists, and administrators — and to have honest conversations about what’s working, what’s not, and where we can help.
The goal isn’t just to evaluate readiness for designation; it’s to partner in building something sustainable.
To use objective data to refine pathways, strengthen careflows, and ultimately deliver the best possible outcomes for patients.
Because for us, the COE designation isn’t a finish line — it’s the beginning of an ongoing collaboration to grow, evolve, and raise the bar for VTE care together.”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation